{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:33:09Z","timestamp":1791261189685,"version":"4.1.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.1210\/jc.2010-0180","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T17:35:05Z","timestamp":1275672905000},"page":"2529-2535","source":"Crossref","is-referenced-by-count":160,"title":["Approach to the Patient with Amiodarone-Induced Thyrotoxicosis"],"prefix":"10.1210","volume":"95","author":[{"given":"Fausto","family":"Bogazzi","sequence":"first","affiliation":[{"name":"Department of Endocrinology (F.B., E.M.), University of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bartalena","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine (L.B.), University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio","family":"Martino","sequence":"additional","affiliation":[{"name":"Department of Endocrinology (F.B., E.M.), University of Pisa, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113575661700_R1","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113575661700_R2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113575661700_R3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association","volume":"61","author":"Bartalena","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.2006.02590.x","article-title":"Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey","volume":"65","author":"Diehl","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists","volume":"69","author":"Tanda","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R6","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2008.03350.x","article-title":"Benzofuran derivatives and the thyroid","volume":"70","author":"Han","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00044011-200828080-00008","article-title":"Atrial fibrillation due to late amiodarone-induced thyrotoxicosis","volume":"28","author":"Kurt","year":"2008","journal-title":"Clin Drug Invest"},{"key":"key\n\t\t\t\t2019041113575661700_R11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113575661700_R12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t2019041113575661700_R13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113575661700_R14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF03347021","article-title":"Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis","volume":"26","author":"Bogazzi","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113575661700_R16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/105072503321319521","article-title":"A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis","volume":"13","author":"Erdogan","year":"2003","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113575661700_R17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113575661700_R18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-08-0553","article-title":"Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?","volume":"159","author":"Tanda","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113575661700_R19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/105072503322239989","article-title":"The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease","volume":"13","author":"Pearce","year":"2003","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113575661700_R20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.1.02122","article-title":"Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality","volume":"154","author":"O'Sullivan","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113575661700_R21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","article-title":"Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole","volume":"9","author":"Martino","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113575661700_R22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0592","article-title":"Treatment of amiodarone-associated thyrotoxicosis","volume":"3","author":"Franklyn","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1210\/jc.2006-2059","article-title":"Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations","volume":"92","author":"Bogazzi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R24","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2009-0940","article-title":"Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study","volume":"94","author":"Bogazzi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrendo.2009.218","article-title":"Thyroid gland: use of glucocorticoids in amiodarone-induced thyrotoxicosis","volume":"5","author":"Vanderpump","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t2019041113575661700_R26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","article-title":"Lithium treatment in amiodarone-induced thyrotoxicosis","volume":"102","author":"Dickstein","year":"1997","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113575661700_R27","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1210\/jcem.86.10.7976","article-title":"Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism","volume":"86","author":"Chopra","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R28","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","article-title":"Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study","volume":"88","author":"Bogazzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1067\/msy.2002.128561","article-title":"Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy","volume":"132","author":"Bogazzi","year":"2002","journal-title":"Surgery"},{"key":"key\n\t\t\t\t2019041113575661700_R30","first-page":"209","article-title":"Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT)","volume":"30","author":"Czarnywojtek","year":"2009","journal-title":"Neuroendocrinol Lett"},{"key":"key\n\t\t\t\t2019041113575661700_R31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2265.2008.03405.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis (AIT)","volume":"70","author":"Albino","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2265.2009.03600.x","article-title":"Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note","volume":"72","author":"Bogazzi","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113575661700_R34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","article-title":"Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease","volume":"30","author":"Gough","year":"2006","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113575661700_R35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00423-006-0112-y","article-title":"Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study","volume":"392","author":"Berti","year":"2007","journal-title":"Langenbecks\u2019 Arch Surg"},{"key":"key\n\t\t\t\t2019041113575661700_R36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/105072504322880391","article-title":"Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?","volume":"14","author":"Ryan","year":"2004","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113575661700_R37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113575661700_R38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03348972","article-title":"Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis","volume":"17","author":"Roti","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113575661700_R39","first-page":"1402","article-title":"Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis","volume":"26","author":"Martino","year":"1985","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t2019041113575661700_R40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem-63-2-485","article-title":"Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism","volume":"63","author":"Wiersinga","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113575661700_R41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-103-1-157_2","article-title":"Amiodarone and antithyroid antibodies","volume":"103","author":"Foresti","year":"1985","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113575661700_R42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bmj.292.6515.227","article-title":"Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone","volume":"292","author":"Monteiro","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t2019041113575661700_R43","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.1986.tb01658.x","article-title":"Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis (AIIT)?","volume":"24","author":"Martino","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113575661700_R44","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9343(84)90726-5","article-title":"Five patients with iodine-induced hyperthyroidism","volume":"77","author":"Rajatanavin","year":"1984","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113575661700_R45","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1136\/bmj.284.6332.1835-a","article-title":"Prednisone in amiodarone-induced thyrotoxicosis","volume":"284","author":"Wimpfheimer","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t2019041113575661700_R46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF03344178","article-title":"Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis","volume":"29","author":"Bogazzi","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113575661700_R47","first-page":"227","article-title":"Amiodarone and the thyroid","author":"Wiersinga","year":"1997","journal-title":"In Weetman AP, Grossman A, eds. Pharmacotherapeutics of the thyroid gland. Heidelberg: Springer;"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/6\/2529\/9066020\/jcem2529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:25:56Z","timestamp":1711531556000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/6\/2529\/2597885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0180","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}